1-3 of 3
Satoshi Nishiwaki
Close
Sort by
Journal Articles

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

Clinical Trials & Observations
Satoshi Nishiwaki, Yu Akahoshi, Mari Morita-Fujita, Hiroaki Shimizu, Naoyuki Uchida, Yukiyasu Ozawa, Takahiro Fukuda, Masatsugu Tanaka, Kazuhiro Ikegame, Shuichi Ota, Yuta Katayama, Satoshi Takahashi, Toshiro Kawakita, Takahide Ara, Makoto Onizuka, Takafumi Kimura, Junji Tanaka, Yoshiko Atsuta, Yasuyuki Arai
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4558–4569.
https://doi.org/10.1182/bloodadvances.2022008032
Published: 2022
Includes: Supplemental data
Journal Articles

Dasatinib-based 2-step induction for adults with Philadelphia chromosome–positive acute lymphoblastic leukemia

Clinical Trials & Observations
Isamu Sugiura, Noriko Doki, Tomoko Hata, Ryuko Cho, Toshiro Ito, Youko Suehiro, Masatsugu Tanaka, Shinichi Kako, Mitsuhiro Matsuda, Hisayuki Yokoyama, Yuichi Ishikawa, Yasuhiro Taniguchi, Maki Hagihara, Yukiyasu Ozawa, Yasunori Ueda, Daiki Hirano, Toru Sakura, Masaaki Tsuji, Tsuyoshi Kamae, Hiroyuki Fujita, Nobuhiro Hiramoto, Masahiro Onoda, Shin Fujisawa, Yoshihiro Hatta, Nobuaki Dobashi, Satoshi Nishiwaki, Yoshiko Atsuta, Yukio Kobayashi, Fumihiko Hayakawa, Shigeki Ohtake, Tomoki Naoe, Yasushi Miyazaki
Journal: Blood Advances
Blood Adv (2022) 6 (2): 624–636.
https://doi.org/10.1182/bloodadvances.2021004607
Published: 2022
Journal Articles

Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph + ALL during both CR1 and CR2

Clinical Trials & Observations
Satoshi Nishiwaki, Yu Akahoshi, Shuichi Mizuta, Akihito Shinohara, Shigeki Hirabayashi, Yuma Noguchi, Takahiro Fukuda, Naoyuki Uchida, Masatsugu Tanaka, Makoto Onizuka, Yukiyasu Ozawa, Shuichi Ota, Souichi Shiratori, Yasushi Onishi, Yoshinobu Kanda, Masashi Sawa, Junji Tanaka, Yoshiko Atsuta, Shinichi Kako
Journal: Blood Advances
Blood Adv (2021) 5 (2): 584–592.
https://doi.org/10.1182/bloodadvances.2020003536
Published: 2021